Chlorambucil: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Chlorambucil. Educational only — not medical advice.
Labeled uses
LEUKERAN (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin’s disease. It is not curative in any of these disorders but may produce clinically useful palliation.
Source: FDA labeling via NIH DailyMed (set 58a3c995…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.